Navigation Links
Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Date:4/8/2008

- Findings Presented at the American College of Cardiology 57th Annual

Scientific Session -

FREMONT, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, presented data from a study providing further confirmation that the Company's multi-protein biomarker panel may aid in the diagnosis of peripheral artery disease (PAD). The research suggests that such a panel may be useful in alerting physicians to the possibility of PAD in patients who might otherwise be undiagnosed. Results of the study were presented as a poster at the American College of Cardiology 57th Annual Scientific Session.

Working in collaboration with researchers at Stanford University, Vermillion intends to develop a blood test for the diagnosis of PAD. In March, the Company entered into an exclusive license agreement with the University to develop and commercialize a biomarker panel used to assess the risk of the disease, which is estimated to affect up to 12 million Americans and can result in severe complications, including amputation, heart attack, stroke and even death.

"Few studies have explored combinations of protein markers to create a distinct biomarker panel score to stratify individuals according to their risk of having PAD. However, our study successfully accomplishes this by discovering a multi-marker panel that could significantly aid in identifying such patients," said Eric T. Fung, M.D., Ph.D., Chief Scientific Officer of Vermillion. "We are pleased with these findings and are developing a clinical trial protocol to generate data for support of a submission to the U.S. Food and Drug Administration (FDA)."

The study was conducted to develop an
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015 ... Open Innovation in Science", som finner sted ... sendes på nett, på  http://www.openinnovationinscience.at , og ... De to største utfordringene innen ... undersøke nye forskningsspørsmål og kompleksiteten av nåværende ...
(Date:7/2/2015)... GLEN ELLYN, Ill. , July 2, 2015 /PRNewswire-USNewswire/ ... and Colton Eakins are gaining invaluable real-world ... Institute of Technology this summer. The students ... Dr. Jeff Wereszczynski,s research group at IIT. ... Professors Dr. Tom Carter , Physics; Dr. ...
(Date:7/2/2015)... ... 2015 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), a ... the acquisition of Turner Medical, Inc ., thus becoming a global leader ... Spine Industry. The acquisition of Turner Medical ideally supplements In’Tech Medical’s product offering, ...
(Date:7/1/2015)... ... ... The next-generation sequencing (NGS) clinical market is poised for huge growth as it ... reveals in its new report that the market drivers of this vibrant industry include ... better diagnostics as part of a molecular diagnostics trend. , The global market is ...
Breaking Biology Technology:Lansering av verdens første Open Innovation-program for utdanning av forskere 2Lansering av verdens første Open Innovation-program for utdanning av forskere 3COD Students Participate in Prestigious Summer Internships 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3
... years or so, the only way to shape metal ... nanotechnology, working with metals involves carving with electron beams ... developed a method to self-assemble metals into complex nanostructures. ... fuel cells and industrial processes and creating microstructured surfaces ...
... Barr Pharmaceuticals,Inc. (NYSE: BRL ) today announced ... favor of its subsidiary, Barr Laboratories, Inc., in ... Pharmaceuticals, Inc. in,connection with Boehringer Ingelheim,s Mirapex(R) Tablets ... In his ruling, District Court Judge Joseph J. ...
... MADISON, N.J., June 26 At a meeting of its,Board ... dividends on,both the Common and Preferred Stock of the Company., ... the outstanding,shares of Common Stock was declared payable on September ... on August 13, 2008., In addition, a dividend of ...
Cached Biology Technology:In 'novel playground,' metals are formed into porous nanostructures 2In 'novel playground,' metals are formed into porous nanostructures 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 2Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 3Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge 4
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
(Date:6/23/2015)... , June 23, 2015  Crossmatch™, a ... authentication solutions, today announced enhanced functionality of its ... solution.  The enhancements build on the native ... DigitalPersona Altus platform and provide expanded mobile ... In today,s environment of increasing cyber-attacks ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... more than 20 years since scientists first discovered the ... how the mutated gene causes disease remain unanswered. ... the most common form of cystic fibrosis, University of ... is "misprocessed" in the pigs and does not end ...
... 2011) -- Measuring the mechanical strength of cancer cell ... cancer, and also suggests why some cancer cells are ... Wan, associate professor of engineering at Northeastern University, Boston, ... secrete mucus to protect against infection. Cancer cells, however, ...
... LAFAYETTE, Ind. - A Purdue University scientist,s nanopolymer would ... test the effectiveness of a widely used class of ... of biochemistry analytical chemistry and a member of the ... pIMAGO nanopolymer that can be used to determine whether ...
Cached Biology News:Pig model of cystic fibrosis improves understanding of disease 2Pig model of cystic fibrosis improves understanding of disease 3Breaking the mucus barrier unveils cancer cell secrets 2Purdue startup hopes to change the way we test cancer drugs 2
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
... A and, until recently, no readily available affinity ... Standard methods for IgM purification generally are multi-step, ... removing all of the major impurities present in ... has developed an easy-to-use affinity matrix and buffer ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...
Biology Products: